BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20842404)

  • 1. Survival and prognosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Hosaka M; Watari H; Mitamura T; Konno Y; Odagiri T; Kato T; Takeda M; Sakuragi N
    Int J Clin Oncol; 2011 Feb; 16(1):33-8. PubMed ID: 20842404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
    Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
    Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Factors of Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer.
    Nanthamongkolkul K; Hanprasertpong J
    Oncol Res Treat; 2018; 41(4):194-198. PubMed ID: 29562222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients.
    Tsuruga T; Fujimoto A; Kawana K; Mori M; Hasumi Y; Kino N; Tomio K; Miura S; Tanikawa M; Sone K; Miyamoto Y; Ikeda Y; Kojima S; Adachi K; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Nakagawa S; Horie K; Yasugi T; Yokota H; Osuga Y; Fujii T
    Int J Clin Oncol; 2016 Apr; 21(2):359-366. PubMed ID: 26438230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
    Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
    Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
    Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and prognosis of IB-IIB cervical carcinoma with common iliac lymph node metastasis.
    Huang L; Zheng M; Liu JH; Xiong Y; Ding H; Tang L; Wang HY
    Chin J Cancer; 2010 Apr; 29(4):431-5. PubMed ID: 20346221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
    Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
    Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy.
    Aslan K; Meydanli MM; Oz M; Tohma YA; Haberal A; Ayhan A
    J Gynecol Oncol; 2020 Jan; 31(1):e1. PubMed ID: 31788991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Satellite lymphovascular space invasion: An independent risk factor in early stage cervical cancer.
    Pol FJ; Zusterzeel PL; van Ham MA; Kuijpers DA; Bulten J; Massuger LF
    Gynecol Oncol; 2015 Sep; 138(3):579-84. PubMed ID: 26126782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
    Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; YĆ¼ce K
    Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome and prognostic factors of laparoscopic radical hysterectomy and pelvic lymphadenectomy in 148 patients with stage IB1 cervical cancer.
    Yan X; Li G; Shang H; Lin F; Yang X; Zheng F
    Int J Gynecol Cancer; 2012 Feb; 22(2):286-90. PubMed ID: 22146764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
    Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
    Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
    Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
    BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer.
    Sakuragi N
    Int J Clin Oncol; 2007 Jun; 12(3):165-75. PubMed ID: 17566838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer.
    Chen Y; Zhang L; Tian J; Fu X; Ren X; Hao Q
    Int J Gynecol Cancer; 2013 Jan; 23(1):157-63. PubMed ID: 23221732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
    Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
    Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.